Biotech

All Articles

Analysts examine Avidity's DMD succeed, showing nuances in information

.Avidity Biosciences impressed real estate investors along with stage 1/2 data in Duchenne muscular ...

Actinogen's cortisol blocker stops working period 2 depression study

.Actinogen Medical's cortisol blocker has actually missed the primary endpoint of a stage 2 study in...

Bivictrix decides going personal only method to take ADC in to clinic

.Antibody-drug conjugates (ADCs) have been at the facility of many a billion-dollar biobuck licensin...

TPG leadings up funds to $580M for expenditures across life sciences

.Property manager TPG, which has actually assisted biotechs including Sionna Therapeutics and also S...

Merck quits period 3 TIGIT trial in lung cancer for futility

.Merck &amp Co.'s TIGIT program has actually endured one more problem. Months after shuttering a per...

After a challenging year, Exscientia folds up in to Recursion

.After a year specified by pipe cuts, the variation of its own chief executive officer and cutbacks,...

Cullinan, after $25M package, restore bispecific to Port

.Cullinan Therapeutics was actually made an impression on good enough along with Harbour BioMed's bi...

A nearer look at Fierce Biotech's Tough 15

.In this full week's episode of "The Best Pipe," we are actually diving into Brutal Biotech's annual...

Lilly experiences period 2 failure of tau-targeting med

.The confetti is actually still flying coming from Eli Lilly's gathering celebrating the approval of...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, firings and re...